1. Home
  2. INAB vs HUBC Comparison

INAB vs HUBC Comparison

Compare INAB & HUBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • HUBC
  • Stock Information
  • Founded
  • INAB 2016
  • HUBC 2017
  • Country
  • INAB United States
  • HUBC Israel
  • Employees
  • INAB N/A
  • HUBC N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • HUBC
  • Sector
  • INAB Health Care
  • HUBC
  • Exchange
  • INAB Nasdaq
  • HUBC Nasdaq
  • Market Cap
  • INAB 14.5M
  • HUBC 21.7M
  • IPO Year
  • INAB 2021
  • HUBC N/A
  • Fundamental
  • Price
  • INAB $0.16
  • HUBC $2.68
  • Analyst Decision
  • INAB Strong Buy
  • HUBC
  • Analyst Count
  • INAB 2
  • HUBC 0
  • Target Price
  • INAB $3.60
  • HUBC N/A
  • AVG Volume (30 Days)
  • INAB 609.1K
  • HUBC 280.9K
  • Earning Date
  • INAB 05-07-2025
  • HUBC 05-01-2025
  • Dividend Yield
  • INAB N/A
  • HUBC N/A
  • EPS Growth
  • INAB N/A
  • HUBC N/A
  • EPS
  • INAB N/A
  • HUBC N/A
  • Revenue
  • INAB N/A
  • HUBC $29,562,000.00
  • Revenue This Year
  • INAB N/A
  • HUBC N/A
  • Revenue Next Year
  • INAB N/A
  • HUBC N/A
  • P/E Ratio
  • INAB N/A
  • HUBC N/A
  • Revenue Growth
  • INAB N/A
  • HUBC N/A
  • 52 Week Low
  • INAB $0.13
  • HUBC $2.15
  • 52 Week High
  • INAB $1.74
  • HUBC $14.00
  • Technical
  • Relative Strength Index (RSI)
  • INAB 36.75
  • HUBC 41.43
  • Support Level
  • INAB $0.15
  • HUBC $2.42
  • Resistance Level
  • INAB $0.17
  • HUBC $2.78
  • Average True Range (ATR)
  • INAB 0.01
  • HUBC 0.30
  • MACD
  • INAB 0.00
  • HUBC 0.11
  • Stochastic Oscillator
  • INAB 3.17
  • HUBC 51.96

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

Share on Social Networks: